Yamamoto Y, Yamashiro H, Schneeweiss A, Muller V, et al. Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational stu Breast Cancer 2022 Sep 3. pii: 10.1007/s12282-022-01399.
PMID: 36057014